Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment

Arthritis Research & Therapy - Tập 6 - Trang 1-35 - 2004
R Westhovens1, P van Riel2, J Sibilia3, G Vratsanos4, I Nuamah4, JC Becker4
1Department of Rheumatology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
2Department of Rheumatology, University Medical Center Nijmegen, Nijmegen, The Netherlands
3Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France
4Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, USA

Thông tin
Thông tin xuất bản

Arthritis Research & Therapy

Tập 6

1-35

Thông tin tác giả